[AMRX] YoY Quarter Result on 31-Dec-2022 [#Q4]

Stock
[AMRX] Amneal Pharmaceuticals, Inc.
Announcement Date
03-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -145.10%
YoY- 8.14%
Quarter Report
AMRX's Result
AMRX's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 616,981 609,759 536,896 510,034 397,328 497,528 293,369 13.18%
PBT -83,461 -7,655 -16,319 -5,477 -57,111 -14,806 62,075 -
Tax 9,883 -1,797 4,140 1,485 7,792 5,524 -119 -
NP -98,649 -5,858 -6,377 -3,037 -32,128 -8,768 61,569 -
Tax Rate - - - - - - 0.19% -
Total Cost 715,630 615,617 543,273 513,071 429,456 506,296 231,800 20.65%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -15.99 -0.96 -1.19 -0.60 -8.09 -1.76 20.99 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.40 -0.04 -0.04 -0.02 -0.23 -0.07 0.54 -
EPS Diluted -0.40 -0.04 -0.04 -0.02 -0.23 -0.07 0.54 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.